PhaseBio Pharmaceuticals PHAS
$ 0.13
7.4%
Quarterly report 2022-Q2
added 08-12-2022
Country |
USA |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Jonathan Mow |
Employees in the company |
50 |
Shares |
43.9 M |
Market Cap[1] |
$ 6.29 M |
EBITDA (LTM) |
$ -90.2 M |
P/E (LTM) |
-0.07 |
P/S (LTM) |
0.57 |
EPS (LTM) |
-1.83 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.